Company intelligence / Profile preview
BioTissue
Miami, Florida, United Statesbiotissue.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
01
Overview
BioTissue has pioneered clinical application of amniotic and umbilical cord tissues for regenerative healing. Their proprietary CryoTek® technology preserves key biological structures that promote anti-inflammatory and anti-scarring effects. The company’s products have been used in over one million clinical applications, supported by more than 420 peer-reviewed publications. Recent studies include use in complex ureteral reconstruction presented at major medical conferences.
- Therapeutic areas
- OtherOphthalmology
- Modalities
- Human birth tissue allografts (amniotic and umbilical cord tissues)
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
03
Partnerships
Mount Sinai Medical Center ("Sharing Miracles" direct acquisition program to expand birth tissue donation)
Beyond the preview
Go deeper on BioTissue.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioTissue.